Capital Research Global Investors Danaher Corp Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Danaher Corp stock. As of the latest transaction made, Capital Research Global Investors holds 5,125,470 shares of DHR stock, worth $1.32 Billion. This represents 0.3% of its overall portfolio holdings.

Number of Shares

5,125,470

Previous 5,072,791 1.04%

Holding current value

$1.32 Billion

Previous $1.17 Billion 9.07%

% of portfolio

0.3%

Previous 0.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$224.58 - $256.19 $11.8 Million - $13.5 Million	52,679 Added 1.04%	5,125,470 $1.28 Billion
Q4 2023 Feb 13, 2024	BUY	$185.1 - $233.13 $53.1 Million - $66.8 Million	286,646 Added 5.99%	5,072,791 $1.17 Billion
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $137 Million - $156 Million	588,817 Added 14.03%	4,786,145 $1.19 Billion
Q2 2023 Aug 11, 2023	BUY	$224.99 - $256.14 $425 Million - $484 Million	1,890,365 Added 81.94%	4,197,328 $1.01 Billion
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $52.8 Million - $61 Million	220,218 Added 10.55%	2,306,963 $581 Million

Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $10.2 Million - $11.9 Million	42,308 Added 2.07%	2,086,745 $554 Million
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $83 Million - $507 Million	336,047 Added 19.67%	2,044,437 $528 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $1.6 Million - $2.02 Million	6,751 Added 0.4%	1,708,390 $433 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $1.04 Million - $1.27 Million	4,028 Added 0.24%	1,701,639 $499 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $316,614 - $356,646	1,084 Added 0.06%	1,697,611 $559 Million
Q3 2021 Nov 15, 2021	SELL	$272.21 - $332.43 $31,304 - $38,229	-115 Reduced 0.01%	1,696,527 $516 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $19,131 - $23,093	-85 Reduced 0.01%	1,696,642 $455 Million
Q1 2021 May 14, 2021	BUY	$212.38 - $245.9 $96.6 Million - $112 Million	454,849 Added 36.63%	1,696,727 $382 Million
Q4 2020 Feb 12, 2021	BUY	$212.5 - $245.46 $96.2 Million - $111 Million	452,527 Added 57.33%	1,241,878 $276 Million
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $96,552 - $117,354	-545 Reduced 0.07%	789,351 $170 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $25,225 - $34,658	-196 Reduced 0.02%	789,896 $140 Million
Q1 2020 May 15, 2020	SELL	$121.39 - $169.05 $97.2 Million - $135 Million	-800,427 Reduced 50.32%	790,092 $109 Million
Q4 2019 Feb 18, 2020	BUY	$133.47 - $153.48 $156,293 - $179,725	1,171 Added 0.07%	1,590,519 $244 Million
Q3 2019 Nov 14, 2019	SELL	$135.4 - $146.47 $21,799 - $23,581	-161 Reduced 0.01%	1,589,348 $230 Million
Q2 2019 Aug 14, 2019	BUY	$124.88 - $143.73 $29.8 Million - $34.3 Million	238,968 Added 17.69%	1,589,509 $227 Million
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $48.8 Million - $66.1 Million	-499,992 Reduced 27.02%	1,350,541 $178 Million
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $853 - $985	-9 Reduced -0.0%	1,850,533 $191 Million
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $115 Million - $127 Million	-1,167,103 Reduced 38.68%	1,850,542 $201 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $201,137 - $216,081	2,093 Added 0.07%	3,017,645 $298 Million
Q1 2018 May 15, 2018	BUY	$92.16 - $103.8 $798,566 - $899,427	8,665 Added 0.29%	3,015,552 $295 Million
Q4 2017 Feb 14, 2018	SELL	$85.26 - $94.62 $38,025 - $42,200	-446 Reduced 0.01%	3,006,887 $279 Million
Q3 2017 Nov 14, 2017	BUY	$79.29 - $88.45 $238 Million - $266 Million	3,007,333	3,007,333 $258 Million

Others Institutions Holding DHR

# of Institutions

2,369

Shares Held

559M

Call Options Held

3.54M

Put Options Held

3.99M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $187B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Danaher Corp Transaction History